Clinical Trials · NCT04861493
Cathelicidin LL-37 Levels in the GCF and the Saliva of Smokers and Non-smokers With Stage III,IV Periodontitis
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Cairo University
- Enrollment
- 60
- Start date
- Feb 2021
- Locations
- 1 site, Egypt
- Primary endpoint
- LL-37 levels in the GCF and saliva